Big Paydays for H1N1 Vaccine Makers

September 2009
Pharmaceutical Representative;Sep2009, Vol. 39 Issue 9, p8
The article reports on the speculation concerning the growth in revenues to be generated by pharmaceutical companies brought by the increase in demand for swine flu vaccines. GlaxoSmithKline anticipates to generate two billion dollars in sales for its vaccines in 2010. Meanwhile, Roche Holding AG expects to gain two billion in 2009 for its Tamiflu drug.


Related Articles

  • Pharma Acts on Swine Flu.  // Pharmaceutical Executive;May2009, Vol. 29 Issue 5, p13 

    The article reports on the move of the pharmaceutical industry to lessen the spread of swine flu in the U.S. As stated, swine flu can be treated with two existing antiviral treatments such as Relenza from GlaxoSmithKline and Tamiflu by Roche/Gilead. With regards to the attack of the virus, the...

  • Pharma Steps Up to Help With Swine Flu.  // Pharmaceutical Representative;Jun2009, Vol. 39 Issue 6, p8 

    The article reports on the move by the pharmaceutical companies Roche and GlaxoSmithKline (GSK) to work with the U.S. government to provide medication to the people most affected by swine influenza. While Roche has pointed out the significance of its drug Tamiflu for the disease, GSK has...

  • RESEARCH & TECHNOLOGY.  // MondayMorning;11/12/2007, Vol. 15 Issue 45, p4 

    This section offers news briefs in the U.S. pharmaceutical industry. Blood-pressure drugs made by GlaxoSmithKline Plc and Roche Holding AG appear to block formation of sticky wads of protein called amyloid plaques that build up in the brains of Alzheimer's patients. Medical components maker...

  • NEWS BRIEFS.  // MondayMorning;4/20/2009, Vol. 17 Issue 15, p5 

    The article offers news briefs related to pharmaceutical industry in the U.S. GlaxoSmithKline PLC and Pfizer Inc. merge into a new company which will develop treatments against HIV virus. Roche Holding AG filed a lawsuit against Mylan Inc. to block the company from acquiring approval from the...

  • News in Brief.  // Nature Reviews Drug Discovery;Jun2009, Vol. 8 Issue 6, p441 

    The article presents news briefs related to drug discoveries in the pharmaceutical industry. Roche Holding AG and the company GlaxoSmithKline are manufacturing new antiviral drugs for the recent swine flu pandemic and developing vaccine manufacturing facilities for it with the use of latest...

  • New routes to bird flu drug.  // Pharmaceutical Technology Europe;Jun2006, Vol. 18 Issue 6, p10 

    The article reports that some individuals are stockpiling Roche's antiviral compound called Tamiflu because of concerns about the H5N1 strain of the avian influenza virus. The demand for Tamiflu is higher than supply and there is a fear that the supply chain wuld be unable to coped with the...

  • COMPANY SPOTLIGHT -- Roche.  // PharmaWatch: Monthly Review;Jun2007, Vol. 6 Issue 6, p31 

    The article focuses on the production of the bird flu vaccine Tamiflu by the Swiss drug company Roche Pharmaceuticals. It is stated that the company's production of Tamiflu has exceeded the demand for the drug since its facility can produce more than 400 million courses of the drug a year. With...

  • DATAMONITOR: F. Hoffmann-La Roche Ltd.  // Roche Group SWOT Analysis;Jul2009, p1 

    The article presents a corporate profile for F. Hoffman-La Roche Ltd., one of the leading research-focused healthcare groups in the world. Roche is based in Basel, Switzerland which specializes in the discovery and commercialization of innovative diagnostic and therapeutic products. The company...

  • EARNINGS ROUNDUP.  // BioWorld Today;10/19/2009, Vol. 20 Issue 201, p3 

    The article offers news briefs on the financial performance of pharmaceutical companies. Cubist Pharmaceuticals Inc. revealed third-quarter net income of 25.4 million U.S. dollars, or 42 cents per share. Roche Holdings AG released drug sales report for the first nine months of 2009, with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics